A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Completed · Phase 2
Conditions studied: Hepatocellular Carcinoma, Liver Cancer, HCC
In brief
This study is to determine whether JX-594 (Pexa-Vec) plus best supportive care is more effective in improving survival than best supportive care in patients with advanced Hepatocellular Carcinoma (HCC) who have failed sorafenib.
Key facts
- Study ID
- NCT01387555
- Run by
- Jennerex Biotherapeutics
- People needed
- 129
- Starts
- 2011-10-08
- Expected to finish
- 2013-10-01
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Moores University of California San Diego Cancer Center — La Jolla, California, United States
- Chao Family Comprehensive Cancer Center — Orange, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- Stanford Hospital and Clinics — Stanford, California, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Billings Clinic — Billings, Montana, United States
- Saint Joseph's Hospital — Paterson, New Jersey, United States
- Montefiore Medical Center — The Bronx, New York, United States
- Gabrail Cancer Center — Canton, Ohio, United States
- University Hospitals Case Medical Center — Cleveland, Ohio, United States
- The Methodist Hospital Department of Surgery — Houston, Texas, United States
- University of Alberta — Edmonton, Alberta, Canada
- University of British Columbia — Vancouver, British Columbia, Canada
- Juravinski Cancer Centre — Hamilton, Ontario, Canada
- Ottawa Hopsital Research Institute — Ottawa, Ontario, Canada
- Hôpitaux Universitaires de Strasbourg - Hôpital Civil — Strasbourg, Alsace, France
- Centre Hospitalier Universitaire Hôpital Saint André — Bordeaux, Aquitaine, France
- Hôpital de la Croix Rousse — Lyon, Auvergne-Rhône-Alpes, France
- CHU d'Estaing — Clermont-Ferrand, Auvergne, France
- Hôpital Purpan — Toulouse, Midi-Pyrenees, France
- Hôpital Saint Antoine, CPP Ile de France V — Paris, Île-de-France Region, France
- Klinikum Rechts der Isar der Technischen Universität München — München, Bavaria, Germany
- Medizinische Hochschule Hannover — Hanover, Lower Saxony, Germany
- Johannes Gutenberg-Universität Mainz — Mainz, Rhineland-Palatinate, Germany
- Universitätsklinikum Hamburg-Eppendorf — Hamburg, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.